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Abstract: The attempt to describe complex diseases by solely genetic determination has not been
successful. There is increasing recognition that the development of disease is often a consequence of
interactions between multiple genetic and environmental factors. To date, much of the research on
environmental determinants of disease has focused on single exposures generally measured at a single
time point. In order to address this limitation, the concept of the exposome has been introduced as a
comprehensive approach, studying the full complement of environmental exposures from conception
onwards. However, exposures are vast, dynamic, and diverse, and only a small proportion can
be reasonably measured due to limitations in technology and feasibility. In addition, the interplay
between genes and exposure as well as between different exposures is complicated and multifaceted,
which leads to difficulties in linking disease or health outcomes with exposures. The large numbers
of collected samples require well-designed logistics. Furthermore, the immense data sets generated
from exposome studies require a significant computational investment for both data analysis and
data storage. This report summarizes discussions during an international exposome symposium
held at Gunma University in Japan regarding the concept of the exposome, challenges in exposome
research, and future perspectives in the field.
Keywords: exposome; metabolomics; exposure; epigenetics; environment
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1. Introduction
Since the human genome was sequenced, an extreme effort has been placed into mapping the
role of genes in the onset of disease. It was expected that we would be able to explain the cause of
disease, as well as understand the genetic basis of health. However, we have found that while the
genetic contribution to different diseases varies, nongenetic factors have much greater attributable risks,
often in the range of 80 to 90% for complex diseases [1]. This dominance of nongenetic components
emphasizes the role of the environment in the risk of the development of chronic disease. In 2010,
there were >50 million global deaths, of which ~50% could be attributed to a small set of exposures
consisting primarily of particulate air pollution, smoking, and diet [2]. This suggests that if we can
identify relevant exposures, we can potentially intervene to reduce the burden of these chronic diseases.
We now know that adverse gene–environment interactions probably influence most chronic
diseases, including respiratory disease, allergy, and cancer [3]. However, the tools for quantitative
assessment of exposures, based on measurements of chemicals in air, water, food, and the human
body, are still limited in their capacity to detect multiple exposures simultaneously. This lack of
comprehensive profiling methods to assess exposure has resulted in a need to rely upon self-reported
information supplemented with population level data from multiple sources (e.g., demographics,
census data, green space surveys, and GIS approaches) to categorize exposures. These self-reports,
with the general exceptions of alcohol consumption and smoking, are unreliable predictors of long-term
exposure levels and are poorly suited for assessing exposome interactions. While the extensive
investment in genomics has successfully illuminated the genetic determinants of diseases, we are still
in the dark ages when it comes to quantifying exposures.
In recognition of this disparity in current knowledge on the health associations of the interactions
between genes and environmental exposures, the term exposome has been proposed to represent
all environmental exposures (including those from diet, behavior, and endogenous sources) from
conception onward [4,5] (Figure 1). The exposome encompasses all nongenetic influences, and
has become of critical relevance to understanding disease etiology [4], with particular interest in
examining the pregnancy exposome and birth cohorts in disease presentation [6]. A few initiatives
have begun, including EXPOsOMICs [7,8], HEALS (Health and Environment-wide Associations based
on Large population Surveys) [9], and HELIX (the Human Early-life Exposome) [10] supported by the
EU; CHEAR (the Children’s Health Exposure Analysis Resource) [11] and HERCULES (The Emory
Health and Exposome Research Center: Understanding Lifetime Exposures) funded by the National
Institute of Environmental Health Sciences (NIEHS) in the US; JECS (the Japan Environment and
Children’s Study) launched in Japan [12]; and the I3CARE International Exposome Center collaboration
between the Chinese University of Hong Kong, the University of Utrecht and the University of
Toronto. However, extensive efforts are still needed to develop the methodologies to capture the
exposome. An international symposium focusing on the exposome was held at Gunma University,
Japan, on 23 October 2018. All of the authors on this report attended the meeting and a list of the talks
is provided in Figure S1. Based upon the current status of the exposome field, this report summarizes
opinions and perspectives with respect to study design, exposure measurement, sample collection and
storage and future outlooks from discussions during the symposium.
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Figure 1. The concept of the exposome. The human exposome is often divided into the external 
exposome (e.g., air, diet, and social factors) and internal exposome (biological responses to 
exposure). Interactions between exposure and genetic factors can lead to disease or adverse health 
outcomes (e.g., aging, allergy, asthma, and cancer). Icons are designed by Freepik. 
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genome in order to establish the role of environmental exposures on a given genetic background. An 
exposure comes from the external environment (e.g., environment, lifestyle, stress, diet, and noise) 
and includes our internal biological processes (e.g., metabolism). The exposome is therefore often 
recognized as being comprised of the external and internal exposome (Figure 1) [15]. The external 
exposome refers to the full set of external exposures and experiences potentially contributing to 
disease or health outcomes (see Table 1 for some examples). The internal exposome includes 
biological responses to the external environment, interactions with exogenous compounds (e.g., 
interactions between diet and the gut microbiome [16,17]) and exogenous compounds entering the 
internal environment via diet, smoking, water, air, etc. 
Figure 1. The concept of the exposome. The hu an exposo e is often divided into the external
exposome (e.g., air, diet, and social factors) and internal exposome (biological responses to exposure).
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(e.g., aging, allergy, asthma, and cancer). Icons ar designed by Freepik.
2. hat is the Exposo e?
The exposome can be defined as the total sum of all exposures from conception onwards [13,14].
The concept of the exposome was introduced as the environmental counterpart to the genome in order
to establish the role of environmental exposures on a given genetic background. An exposure comes
from the external environment (e.g., environment, lifestyle, stress, diet, and noise) and includes our
internal biological processes (e.g., metabolism). The exposome is therefore often recognized as being
comprised of the external and internal exposome (Figure 1) [15]. The external exposome refers to the
full set of external exposures and experiences potentially contributing to disease or health outcomes
(see Table 1 for some examples). The internal exposome includes biological responses to the external
environment, interactions with exogenous co pounds (e.g., interactions between diet and the gut
microbiome [16,17]) and exogenous compounds entering the internal environment via diet, smoking,
water, air, etc.
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Table 1. Relevant exposures for inclusion in exposome studies.
Exposure Group Exposure
External
- Meteorology Climate change, temperature, humidity, wind, atmospheric pressure
- Outdoor exposures NO2, SO2, CO, O3, VOCs, PM, radiation, UV, traffic, pollen
- Built environment Population density, building density, facilities, green space, walkability,
neighborhood safety, accessibility to resources (e.g., hospitals, bus stations), noise
- Home environment VOCs, PM, NO2, CO, aldehydes, metals, plasticizers, dust, pets, pests, allergen
(e.g., house dust mites), mold, fungi, microbes, endotoxin
- Personal behavior Diets, physical activity, tobacco smoke, alcohol, drugs, sleep, sex, cosmetics
- Social economic factors Social factors, education, economy, psychological and mental stress
- Food and water contaminants Fertilizers, metals, pesticides, plasticizers, DBPs, PCBs, flame retardants, PFASs
- Medications Medicines, surgeries
- Occupational exposures Chemicals, dust, metals, virus, animal proteins, plants, heat/cold stress
Internal
Primary external exposures and associated metabolites, epigenetic
(e.g., methylations, histone modifications),
microbiome/metabolome/proteome/transcriptome/genome changes, etc.
Abbreviations: VOCs: volatile organic compounds; PM: particulate matter; PCB: polychlorinated biphenyl; NO2:
nitrogen dioxide; UV: ultraviolet; CO: carbon oxide; O3: ozone; SO2: sulfur dioxide; DBPs: (water) disinfection
by-products; PFASs: per- and polyfluoroalkyl substances.
3. How to Perform an Exposome Study?
Implementing the exposome concept to explain the causalities of chronic disease poses multiple
challenges [18]. Herein, we discuss four basic questions: (1) Which variables should be included in the
study design? (2) How to develop methods to comprehensively assess all exposures from both external
and internal sources? (3) Which sample types can be collected and how to effectively manage large
sample numbers? (4) How to dissect the associations between exposome data and health end points?
3.1. Study Design
As the field of exposome science continues to develop, a fundamental question is how to perform
an exposome study. There are no clear methodologies and only a few examples in the literature.
To date, three overall strategies have been applied. The first one is called “bottom-up”, in which
external exposures are comprehensively measured and then linked to disease or health outcomes [6,19].
The second strategy is “top-down”, in which omics technologies (e.g., metabolomics, adductomics, and
epigenomics) are applied to identify biomarkers of exposures and new causes of or associations with
disease [20,21]. The last approach is “meet-in-the-middle”, in which the association between exposures
and disease or biomarkers of exposures are initially investigated and then the relationship between
disease and biomarkers is assessed. No matter which strategy is applied, an exposome study should be
assumption-directed. For example, if the study is designed to explore the role of environmental factors
on asthma, information on all exposures that could potentially affect airway inflammation should be
collected [22]. However, this will come at the cost of not identifying rare exposures that are not yet
known to correlate with a given disease; whereas, if the study aims to discover effects of exposures on
unexpected health outcomes, it is desirable to include all measurable exposures in a given time period.
However, this approach is not feasible and therefore some basic assumptions must be made in the initial
experimental design in terms of which exposure variables are most relevant to the study at hand. The
epidemiology field is well versed in designing these complex studies, with multiple options depending
upon the study design (e.g., cross-sectional, longitudinal, cohort, and case–control). The different study
designs can also complement one another, and there may be advantages in integrating them to gain an
improved understanding of the effects of exposure.
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One key challenge is to identify cause and effect in exposome association studies. While it is
not possible to fully assign cause and effect in the design of an exposome study, some concepts
can aid in interpreting findings. Due to the observational and cross-sectional study design of most
studies conducted to date, there is often a temporal discordance between exposure and observed
effect. It is therefore difficult to understand the effect of potential exposures from single spot samples.
Exposome-based studies therefore benefit from longitudinal sampling, particular during critical life
stages [23]. Accordingly, study design needs to incorporate multiple longitudinal time periods as well
as temporal variability [24]. Many exposome studies employ birth cohorts, which enables studies to
monitor the health trajectory of a population over time (including critical periods early in life) and
investigation of the effects of multiple exposures [6].
The potential scale of exposome work can be massive by definition and is often beyond the ability
of a single research group, requiring collaborations. It is not necessary to initiate an exposome study
from scratch, and finished or ongoing associated projects can be leveraged and re-analyzed to suit
exposome research aims. For example, HELIX combines six established and ongoing longitudinal
population-based birth cohort studies in six European countries, serving as a good example of
integrating existing resources [19].
Nonetheless, there remain challenges of study design and exposure reconstruction. First, for rare
and low frequency disorders, especially those with long latency periods, establishing prospective
studies is not always feasible as it would require very large samples sizes and many years of follow-up
to obtain sufficient cases. For example, amyotrophic lateral sclerosis (ALS) is a disease that occurs with a
frequency of 2 per 100,000 and is most often diagnosed in the fifth decade of life [25]. To study the early
life environmental determinants of this neurodegenerative disorder, a sample size in excess of a million
participants who are studied over decades would be needed in a prospective cohort design. A second
major challenge is to retrospectively measure fetal exposure, which is a critical period of development.
Many extant studies do not have biobanked samples of umbilical cord blood. An alternative to this
approach is the use of naturally shed deciduous teeth or permanent adult teeth. Deciduous teeth
commence development prenatally and grow in an incremental pattern (akin to growth rings in trees).
Using beam-based methods, such as laser ablation, it is now possible to reconstruct past exposures
(e.g., metals and organic chemicals) at fine temporal resolution, including over the fetal developmental
period [26,27]. However, this approach requires significant expertise in dental tissue biology and has
relatively complex sample preparation methods. For the external environment, there exist methods
to reconstruct particulate air pollution, ambient temperature, green-space, light-at-night, and other
measures using satellite-based monitoring [28–30]. These tools allow fine temporal scale reconstruction
of historical exposure that may be added to existing studies.
An exposome study can also be fulfilled without extensively measuring exposures in large-scale
biological samples. For example, efforts have been made to dissect the relationship between the
genome and environment in large data streams such as electronic health records and epidemiological
cohorts using tools of bioinformatics [31,32]. In a recent study [33], a large health insurance dataset
was analyzed to assess the genetic and environmental contributions of 560 disease-related phenotypes
in 56,396 twin pairs and 724,513 sibling pairs. The contribution of specific environmental risk factors
like socioeconomic status and air pollution in phenotype were also estimated. Notably, this type of
study requires massive data sets, vast experience in data analysis as well as comprehensive knowledge
in genetics and epidemiology.
3.2. Which Exposures to Measure
Due to the comprehensive nature of the exposome, it is essentially not possible to measure
the full complement of exposures. It then becomes a question of which exposures are the most
informative as well as most realistic to obtain. A nonexclusive list of potential exposome categories
and examples is shown in Table 1. External exposures such as climate and air quality can be acquired
from local meteorological stations and environment databases (e.g., Global Environmental Database,
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Japan). The use of GIS (Geographical Intelligent Software) is also particularly useful for acquiring
this type of data. Personal life style and behavior as well as social factors are typically obtained
by questionnaires or self-reports. Smartphone-based personal wearable devices can monitor basic
functions including physical activity, heart rate, sleep quality, food nutrition, etc. Silicone bands that
are capable of capturing airborne or skin contact exposures including pesticides and flame retardants
are now available (MyExposome, Inc., Corvallis, OR, USA) [34,35]. More professional devices have
also been invented, for example a modified MicroPEM™ (RTI International, Research Triangle Park,
NC, USA), which includes an infrared laser nephelometer, a PTFE (polytetrafluoroethylene) or PES
(polyethersulfone) filter, and a cartridge filled with zeolite adsorbent beads that can capture hundreds
of airborne biological and chemical exposures [36].
Current exposome studies mostly focus on measurable environmental exposures (e.g., air pollution,
smoke, and occupational exposure) due to knowledge and technology limitations. However, there is a
need to have as comprehensive of a measurement as possible. Measurable internal biological changes
can serve as good indicators of external exposures, for example, telomere length is a master integrator of
stressors that result from a variety of lifestyle and behavioral factors [37]. More comprehensively, omics
technologies are recognized as promising approaches for obtaining biomarkers of exposure, biomarkers
of effect, and biomarkers of susceptibility. In particular, it would be useful to identify biomarkers of
susceptibility in order to identify at-risk or sensitive populations for certain environmental exposures.
While top-down measurement of exposome signals through measurement of the global biological
response using omics technologies addresses the issue to some extent, the current analytical technology
is not sufficiently sensitive or flexible to capture and identify the components of the exposome in a
single method [38,39]. Accordingly, current approaches will have to focus on specific chemical classes
and integrate multi-platform data to generate more informative datasets.
3.3. Sample Collection and Management
The most common and readily available biological samples include blood and urine. Additional
matrices of interest include feces, hair, sputum [40], and breast milk. Another approach that has
been particularly successful is the use of teeth [41–43]. As mentioned earlier, the incremental and
archival nature of teeth is an attractive option for obtaining detailed information on exposure timing.
For example, a tooth-matrix biomarker method identified that metal toxicant uptake and essential
element deficiency increased the risk of autism spectrum disorder in children [44].
Exposome studies generally involve large cohorts in order to have sufficient statistical power
to detect meaningful effect sizes. For example, the JECS study is only halfway through its
targeted completion, and has already amassed >5,000,000 individual sample tubes collected from
>250,000 participants (>100,000 expecting mothers, >100,000 children, and >50,000 fathers). Exposure
to environmental factors are being assessed by chemical analyses of biospecimens (e.g., blood, cord
blood, urine, breast milk, and hair), household environment measurements, and computational
simulations using monitoring data (e.g., ambient air quality monitoring), as well as questionnaires.
The logistics of managing this many samples should not be underestimated and protocols with respect
to sample collection, pretreatment, transportation, aliquoting, labeling, and storage should be decided
early in the study design [12]. Biological samples should be aliquoted into small volumes to minimize
potential effects from repeated freeze–thaw cycles [45]. Another important component is the question
of sample integrity during storage. Some cohort studies may include samples that are decades old and
there is little information on the stability of materials overtime. It would be particularly valuable to
have molecular markers of sample viability, and there have been some initial efforts in this area [46,47].
3.4. Exposome Data Analysis
The basic concept of the exposome is to determine how environmental factors affect human
health. Therefore, when it comes to data analysis, it is vital to link exposures to disease or health [48].
However, prior to data analysis, obtained exposures (variants) need to be preprocessed or cleaned
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(e.g., address missing values, classify the exposures into categories, calculate the correlations between
and within categories, narrow down the variant dimensions by excluding co-occurring exposures,
and data transformation). These efforts are nontrivial, and require a clear data analysis plan prior to
study initiation.
While GWAS has been extensively used to identify genetic variants associated with disease,
the concept of exposome-wide association study (EWAS) is still relatively new [9,49]. EWAS borrows
the methods of GWAS to identify environmental factors that are associated with specific phenotypes.
The logical next step in these analyses is the concept of genome-wide by environment interaction
studies (GWEIS) in large-scale settings [50]. GWEIS approaches have been applied in various studies
to investigate if there are specific variants associated with disease risk following exposure, or to
identify relevant disease mechanisms. For example, novel loci for childhood asthma in relation to
traffic-related air pollution exposure have been identified in recent GWEIS [51], as well as loci for
respiratory symptoms in relation to occupational exposures [52] and for serum lipids in relation to
smoking [53]. However, appropriate statistical models to conduct genome-wide studies in a true
exposome setting have yet to be developed and well-powered studies to be performed. Likewise,
epigenome-wide studies have been conducted for single environmental exposures linking, for example,
maternal tobacco smoke during pregnancy [54] and prenatal air pollution exposure [55] to newborn
DNA methylation changes, but no comprehensive exposome–epigenetics study has been published to
date. Yet, these epigenetics studies highlight the complex interplay between environmental exposures
and our genetic setup.
An interesting method to present exposure interactions is the exposome interaction network,
which combines human- and environment-related exposures. Data analysis was designed to examine
the intersection of interacting ecosystems (e.g., human-related bacteria, fungi, and arthropods).
An exposome cloud was generated by querying species-interaction databases based on all measured
biotic exposures. The number of nodes/edges/average interactions in the cloud provides an overview
of personal lifestyles and work–home routines [36]. This method represents a realistic approach to
interrogate and analyze this large body of data in a meaningful fashion that is accessible for the
interested reader.
4. Future Perspectives
There is a need to define the composition of the exposome in order to assist in experimental design
and to move the field forward. A number of efforts have already been made to develop exposome
databases [56–58]. For example, metabolomics databases have begun to focus on exogenous chemicals
and METLIN has expanded its library to include >700,000 chemicals [59]. In addition, there are decades
of studies performed in the environmental field on a compound-by-compound basis. Accordingly,
a vast, scattered exposure database already exists, representing an opportunity to collect a large body
of information on the effects of exposure. There are also significant data available from workplace and
occupational exposures [60]. In addition, multiple groups have performed targeted environmental
exposures [61–63] as well as work performed in model organisms [64]. However, in order to make
effective use of these resources, there is a need for extensive data sharing and for platforms capable of
processing and analyzing large-scale data.
The standard approach to an exposome study generally involves large numbers of individuals
in order to obtain reliable exposure-phenotype interactions. However, it is also possible to focus on
fewer participants for a longer period (i.e., longitudinal study). In a recent study, 15 individuals were
followed for up to 890 days to discover the diversity and dynamics of the exposome and its potential
impact on human health [36]. Apart from revealing the casualties of disease, the exposome might
also be useful for providing individual feedback (e.g., health status, local environment and quality),
heritability prediction, and identifying individuals at risk. The exposome will most likely become an
important component of personalized health care, together with genetic and other omics data, in order
to establish which exposures may result in adverse health effects for individuals. The combination of
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genetic determinants with exposure data may be able to identify susceptible subpopulations that have
higher risk levels of disease development in association with specific exposures. It is likely that the near
future of health care will incorporate a combination of personal, home, and work space monitoring
to measure exposure profiles, which will be correlated with individual susceptibility to disease and
ultimately assist in maintaining health.
5. Concluding Remarks
There is a strong link between environmental exposure and disease onset; however, few efforts
have been made to determine the total human exposure from our environment. The advent of the
exposome is an attempt to understand the important, but complex nature of the interactions between
environmental exposures, genetics, and health. An exposome study must incorporate multiple potential
confounders including population vs. individual variation, age effects, seasonal effects, spatial effects,
etc. In the future, it will be important to systematically expand the depth and breadth of our exposure
knowledge. More importantly, the development of exposome science will require extraordinary efforts
in many disciplines (environmental science, analytical chemistry, bioinformatics, genetics, systems
biology, and epidemiology). Scientists from these fields, policy-makers, and funding agencies need to
harmonize their approach in order to tackle the complexity of the exposome, which offers nothing less
than the potential to understand the etiology of heterogeneous diseases.
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Figure S1: Program of the 5th International Symposium of the Gunma University Initiative for Advanced Research
(GIAR).
Author Contributions: P.Z. and C.E.W. planned and drafted the manuscript; M.A., R.C., T.I., M.J., I.M., E.M., M.P.,
F.T., and M.R.W. assisted in editing and reviewing.
Funding: This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant
(JP18H06121, JP19K21239, JP19K17662) and the Japanese Environment Research and Technology Development
Fund (No. 5-1752). We acknowledge the Gunma University Initiative for Advanced Research (GIAR), the STINT
Foundation, the Swedish Heart Lung Foundation (HLF 20170734, HLF 20180290), and the Swedish Research
Council (2016-02798). M.A. was supported by NIH (DP2ES025453). M.J. was supported by NIH (R01ES027595).
I.M. was supported by a JSPS postdoctoral fellowship (P17774). E.M. was supported by grants from the European
Research Council (757919), the Swedish Research Council, and the Strategic Research Area Epidemiology at KI.
M.P. was supported by NIH (P30 ES09089).
Acknowledgments: We thank Komugi Kanazawa and Kyoko Ogura for extensive support for the planning of
the symposium.
Conflicts of Interest: The authors declare no conflicts of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. Willett, W.C. Balancing life-style and genomics research for disease prevention. Science 2002, 296, 695–698.
[CrossRef] [PubMed]
2. Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; Amann, M.; Anderson, H.R.;
Andrews, K.G.; Aryee, M.; et al. A comparative risk assessment of burden of disease and injury attributable
to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden
of Disease Study 2010. Lancet 2012, 380, 2224–2260. [CrossRef]
3. Rappaport, S.M. Genetic Factors Are Not the Major Causes of Chronic Diseases. PLoS ONE 2016, 11, e0154387.
[CrossRef]
4. Rappaport, S.M.; Barupal, D.K.; Wishart, D.; Vineis, P.; Scalbert, A. The blood exposome and its role in
discovering causes of disease. Environ. Health Perspect. 2014, 122, 769–774. [CrossRef]
5. Wild, C.P. The exposome: From concept to utility. Int. J. Epidemiol. 2012, 41, 24–32. [CrossRef] [PubMed]
6. Robinson, O.; Basagana, X.; Agier, L.; de Castro, M.; Hernandez-Ferrer, C.; Gonzalez, J.R.; Grimalt, J.O.;
Nieuwenhuijsen, M.; Sunyer, J.; Slama, R.; et al. The Pregnancy Exposome: Multiple Environmental
Exposures in the INMA-Sabadell Birth Cohort. Environ. Sci. Technol. 2015, 49, 10632–10641. [CrossRef]
Metabolites 2019, 9, 106 9 of 11
7. Turner, M.C.; Vineis, P.; Seleiro, E.; Dijmarescu, M.; Balshaw, D.; Bertollini, R.; Chadeau-Hyam, M.; Gant, T.;
Gulliver, J.; Jeong, A.; et al. EXPOsOMICS: Final policy workshop and stakeholder consultation. BMC Public
Health 2018, 18, 260. [CrossRef]
8. Vineis, P.; Chadeau-Hyam, M.; Gmuender, H.; Gulliver, J.; Herceg, Z.; Kleinjans, J.; Kogevinas, M.;
Kyrtopoulos, S.; Nieuwenhuijsen, M.; Phillips, D.H.; et al. The exposome in practice: Design of the
EXPOsOMICS project. Int. J. Hyg. Environ. Health 2017, 220, 142–151. [CrossRef] [PubMed]
9. Steckling, N.; Gotti, A.; Bose-O’Reilly, S.; Chapizanis, D.; Costopoulou, D.; De Vocht, F.; Gari, M.; Grimalt, J.O.;
Heath, E.; Hiscock, R.; et al. Biomarkers of exposure in environment-wide association studies—Opportunities
to decode the exposome using human biomonitoring data. Environ. Res. 2018, 164, 597–624. [CrossRef]
10. Vrijheid, M.; Slama, R.; Robinson, O.; Chatzi, L.; Coen, M.; van den Hazel, P.; Thomsen, C.; Wright, J.;
Athersuch, T.J.; Avellana, N.; et al. The human early-life exposome (HELIX): Project rationale and design.
Environ. Health Perspect. 2014, 122, 535–544. [CrossRef]
11. Balshaw, D.M.; Collman, G.W.; Gray, K.A.; Thompson, C.L. The Children’s Health Exposure Analysis
Resource: Enabling research into the environmental influences on children’s health outcomes. Curr. Opin.
Pediatr. 2017, 29, 385–389. [CrossRef] [PubMed]
12. Kawamoto, T.; Nitta, H.; Murata, K.; Toda, E.; Tsukamoto, N.; Hasegawa, M.; Yamagata, Z.; Kayama, F.;
Kishi, R.; Ohya, Y.; et al. Rationale and study design of the Japan environment and children’s study (JECS).
BMC Public Health 2014, 14, 25. [CrossRef] [PubMed]
13. Rappaport, S.M. Implications of the exposome for exposure science. J. Expos. Sci. Environ. Epidemiol. 2011,
21, 5–9. [CrossRef] [PubMed]
14. Wild, C.P. Complementing the genome with an “exposome”: The outstanding challenge of environmental
exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomark. Prev. 2005, 14, 1847–1850.
[CrossRef] [PubMed]
15. Vrijheid, M. The exposome: A new paradigm to study the impact of environment on health. Thorax 2014, 69,
876–878. [CrossRef] [PubMed]
16. Ussar, S.; Griffin, N.W.; Bezy, O.; Fujisaka, S.; Vienberg, S.; Softic, S.; Deng, L.; Bry, L.; Gordon, J.I.; Kahn, C.R.
Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and
Metabolic Syndrome. Cell Metab. 2015, 22, 516–530. [CrossRef]
17. Singh, A.; Zapata, R.C.; Pezeshki, A.; Workentine, M.L.; Chelikani, P.K. Host genetics and diet composition
interact to modulate gut microbiota and predisposition to metabolic syndrome in spontaneously hypertensive
stroke-prone rats. FASEB J. 2019. [CrossRef]
18. Wild, C.P.; Scalbert, A.; Herceg, Z. Measuring the exposome: A powerful basis for evaluating environmental
exposures and cancer risk. Environ. Mol. Mutagenesis 2013, 54, 480–499. [CrossRef]
19. Maitre, L.; de Bont, J.; Casas, M.; Robinson, O.; Aasvang, G.M.; Agier, L.; Andrusaityte, S.; Ballester, F.;
Basagana, X.; Borras, E.; et al. Human Early Life Exposome (HELIX) study: A European population-based
exposome cohort. BMJ Open 2018, 8, e021311. [CrossRef]
20. Cooke, M.S.; Hu, C.W.; Chang, Y.J.; Chao, M.R. Urinary DNA adductomics—A novel approach for exposomics.
Environ. Int. 2018, 121, 1033–1038. [CrossRef]
21. Lu, S.S.; Grigoryan, H.; Edmands, W.M.; Hu, W.; Iavarone, A.T.; Hubbard, A.; Rothman, N.; Vermeulen, R.;
Lan, Q.; Rappaport, S.M. Profiling the Serum Albumin Cys34 Adductome of Solid Fuel Users in Xuanwei
and Fuyuan, China. Environ. Sci. Technol. 2017, 51, 46–57. [CrossRef] [PubMed]
22. Subramanian, A.; Khatri, S.B. The Exposome and Asthma. Clin. Chest Med. 2019, 40, 107–123. [CrossRef]
[PubMed]
23. Shaffer, R.M.; Smith, M.N.; Faustman, E.M. Developing the Regulatory Utility of the Exposome: Mapping
Exposures for Risk Assessment through Lifestage Exposome Snapshots (LEnS). Environ. Health Perspect.
2017, 125, 085003. [CrossRef] [PubMed]
24. Jones, D.P. Sequencing the exposome: A call to action. Toxicol. Rep. 2016, 3, 29–45. [CrossRef] [PubMed]
25. Chio, A.; Logroscino, G.; Traynor, B.J.; Collins, J.; Simeone, J.C.; Goldstein, L.A.; White, L.A.
Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature.
Neuroepidemiology 2013, 41, 118–130. [CrossRef] [PubMed]
26. Arora, M.; Austin, C.; Sarrafpour, B.; Hernandez-Avila, M.; Hu, H.; Wright, R.O.; Tellez-Rojo, M.M.
Determining prenatal, early childhood and cumulative long-term lead exposure using micro-spatial deciduous
dentine levels. PLoS ONE 2014, 9, e97805. [CrossRef] [PubMed]
Metabolites 2019, 9, 106 10 of 11
27. Velthorst, E.; Smith, L.; Bello, G.; Austin, C.; Gennings, C.; Modabbernia, A.; Franke, N.; Frangou, S.;
Wright, R.; de Haan, L.; et al. New Research Strategy for Measuring Pre- and Postnatal Metal Dysregulation
in Psychotic Disorders. Schizophr. Bull. 2017, 43, 1153–1157. [CrossRef] [PubMed]
28. Sorek-Hamer, M.; Just, A.C.; Kloog, I. Satellite remote sensing in epidemiological studies. Curr. Opin. Pediatr.
2016, 28, 228–234. [CrossRef] [PubMed]
29. Rosenfeld, A.; Dorman, M.; Schwartz, J.; Novack, V.; Just, A.C.; Kloog, I. Estimating daily minimum,
maximum, and mean near surface air temperature using hybrid satellite models across Israel. Environ. Res.
2017, 159, 297–312. [CrossRef]
30. Bose, S.; Ross, K.R.; Rosa, M.J.; Chiu, Y.M.; Just, A.; Kloog, I.; Wilson, A.; Thompson, J.; Svensson, K.;
Rojo, M.M.T.; et al. Prenatal particulate air pollution exposure and sleep disruption in preschoolers: Windows
of susceptibility. Environ. Int. 2019, 124, 329–335. [CrossRef] [PubMed]
31. Manrai, A.K.; Ioannidis, J.P.A.; Patel, C.J. Signals Among Signals: Prioritizing Non-genetic Associations in
Massive Datasets. Am. J. Epidemiol. 2019. [CrossRef] [PubMed]
32. Le Goallec, A.; Patel, C.J. Age-dependent co-dependency structure of biomarkers in the general population
of the United States. Aging 2019, 11, 1404–1426. [CrossRef] [PubMed]
33. Lakhani, C.M.; Tierney, B.T.; Manrai, A.K.; Yang, J.; Visscher, P.M.; Patel, C.J. Repurposing large health
insurance claims data to estimate genetic and environmental contributions in 560 phenotypes. Nat. Genet.
2019, 51, 327–334. [CrossRef] [PubMed]
34. O’Connell, S.G.; Kincl, L.D.; Anderson, K.A. Silicone wristbands as personal passive samplers. Environ. Sci.
Technol. 2014, 48, 3327–3335. [CrossRef] [PubMed]
35. Dixon, H.M.; Scott, R.P.; Holmes, D.; Calero, L.; Kincl, L.D.; Waters, K.M.; Camann, D.E.; Calafat, A.M.;
Herbstman, J.B.; Anderson, K.A. Silicone wristbands compared with traditional polycyclic aromatic
hydrocarbon exposure assessment methods. Anal. Bioanal. Chem. 2018, 410, 3059–3071. [CrossRef]
[PubMed]
36. Jiang, C.; Wang, X.; Li, X.; Inlora, J.; Wang, T.; Liu, Q.; Snyder, M. Dynamic Human Environmental Exposome
Revealed by Longitudinal Personal Monitoring. Cell 2018, 175, 277–291.e31. [CrossRef]
37. Epel, E.S.; Blackburn, E.H.; Lin, J.; Dhabhar, F.S.; Adler, N.E.; Morrow, J.D.; Cawthon, R.M. Accelerated
telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 2004, 101, 17312–17315. [CrossRef]
38. Rappaport, S.M. Biomarkers intersect with the exposome. Biomarkers 2012, 17, 483–489. [CrossRef]
39. Dennis, K.K.; Marder, E.; Balshaw, D.M.; Cui, Y.; Lynes, M.A.; Patti, G.J.; Rappaport, S.M.; Shaughnessy, D.T.;
Vrijheid, M.; Barr, D.B. Biomonitoring in the Era of the Exposome. Environ. Health Perspect. 2017, 125, 502–510.
[CrossRef]
40. Bessonneau, V.; Pawliszyn, J.; Rappaport, S.M. The Saliva Exposome for Monitoring of Individuals’ Health
Trajectories. Environ. Health Perspect. 2017, 125, 077014. [CrossRef]
41. Andra, S.S.; Austin, C.; Arora, M. The tooth exposome in children’s health research. Curr. Opin. Pediatr.
2016, 28, 221–227. [CrossRef] [PubMed]
42. Andra, S.S.; Austin, C.; Wright, R.O.; Arora, M. Reconstructing pre-natal and early childhood exposure to
multi-class organic chemicals using teeth: Towards a retrospective temporal exposome. Environ. Int. 2015,
83, 137–145. [CrossRef] [PubMed]
43. Arora, M.; Austin, C. Teeth as a biomarker of past chemical exposure. Curr. Opin. Pediatr. 2013, 25, 261–267.
[CrossRef] [PubMed]
44. Arora, M.; Reichenberg, A.; Willfors, C.; Austin, C.; Gennings, C.; Berggren, S.; Lichtenstein, P.; Anckarsater, H.;
Tammimies, K.; Bolte, S. Fetal and postnatal metal dysregulation in autism. Nat. Commun. 2017, 8, 15493.
[CrossRef] [PubMed]
45. Cuhadar, S.; Koseoglu, M.; Atay, A.; Dirican, A. The effect of storage time and freeze-thaw cycles on the
stability of serum samples. Biochem. Med. 2013, 23, 70–77. [CrossRef]
46. Wheelock, A.M.; Paulson, L.; Litton, J.E.; EuPA Biobank Initiative Group. The EuPA Biobank Initiative:
Meeting the future challenges of biobanking in proteomics & systems medicine. J. Proteom. 2015, 127,
414–416. [CrossRef]
47. Liu, X.; Hoene, M.; Yin, P.; Fritsche, L.; Plomgaard, P.; Hansen, J.S.; Nakas, C.T.; Niess, A.M.; Hudemann, J.;
Haap, M.; et al. Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-
C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood. Clin. Chem.
2018, 64, 810–819. [CrossRef]
Metabolites 2019, 9, 106 11 of 11
48. Patel, C.J. Analytic Complexity and Challenges in Identifying Mixtures of Exposures Associated with
Phenotypes in the Exposome Era. Curr. Epidemiol. Rep. 2017, 4, 22–30. [CrossRef]
49. Patel, C.J.; Bhattacharya, J.; Butte, A.J. An Environment-Wide Association Study (EWAS) on type 2 diabetes
mellitus. PLoS ONE 2010, 5, e10746. [CrossRef]
50. Dunn, E.C.; Wiste, A.; Radmanesh, F.; Almli, L.M.; Gogarten, S.M.; Sofer, T.; Faul, J.D.; Kardia, S.L.; Smith, J.A.;
Weir, D.R.; et al. Genome-Wide Association Study (Gwas) and Genome-Wide by Environment Interaction
Study (Gweis) of Depressive Symptoms in African American and Hispanic/Latina Women. Depress. Anxiety
2016, 33, 265–280. [CrossRef]
51. Gref, A.; Merid, S.K.; Gruzieva, O.; Ballereau, S.; Becker, A.; Bellander, T.; Bergstrom, A.; Bosse, Y.; Bottai, M.;
Chan-Yeung, M.; et al. Genome-Wide Interaction Analysis of Air Pollution Exposure and Childhood Asthma
with Functional Follow-up. Am. J. Respir. Crit. Care Med. 2017, 195, 1373–1383. [CrossRef] [PubMed]
52. Zeng, X.; Vonk, J.M.; van der Plaat, D.A.; Faiz, A.; Pare, P.D.; Joubert, P.; Nickle, D.; Brandsma, C.A.;
Kromhout, H.; Vermeulen, R.; et al. Genome-wide interaction study of gene-by-occupational exposures on
respiratory symptoms. Environ. Int. 2019, 122, 263–269. [CrossRef] [PubMed]
53. Bentley, A.R.; Sung, Y.J.; Brown, M.R.; Winkler, T.W.; Kraja, A.T.; Ntalla, I.; Schwander, K.; Chasman, D.I.;
Lim, E.; Deng, X.; et al. Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals
identifies new loci associated with serum lipids. Nat. Genet. 2019, 51, 636–648. [CrossRef] [PubMed]
54. Joubert, B.R.; Felix, J.F.; Yousefi, P.; Bakulski, K.M.; Just, A.C.; Breton, C.; Reese, S.E.; Markunas, C.A.;
Richmond, R.C.; Xu, C.J.; et al. DNA Methylation in Newborns and Maternal Smoking in Pregnancy:
Genome-wide Consortium Meta-analysis. Am. J. Hum. Genet. 2016, 98, 680–696. [CrossRef] [PubMed]
55. Gruzieva, O.; Xu, C.J.; Breton, C.V.; Annesi-Maesano, I.; Anto, J.M.; Auffray, C.; Ballereau, S.; Bellander, T.;
Bousquet, J.; Bustamante, M.; et al. Epigenome-Wide Meta-Analysis of Methylation in Children Related to
Prenatal NO2 Air Pollution Exposure. Environ. Health Perspect. 2017, 125, 104–110. [CrossRef] [PubMed]
56. Neveu, V.; Moussy, A.; Rouaix, H.; Wedekind, R.; Pon, A.; Knox, C.; Wishart, D.S.; Scalbert, A.
Exposome-Explorer: A manually-curated database on biomarkers of exposure to dietary and environmental
factors. Nucleic Acids Res. 2017, 45, D979–D984. [CrossRef] [PubMed]
57. Faisandier, L.; Bonneterre, V.; De Gaudemaris, R.; Bicout, D.J. Occupational exposome: A network-based
approach for characterizing Occupational Health Problems. J. Biomed. Inform. 2011, 44, 545–552. [CrossRef]
58. Wishart, D.; Arndt, D.; Pon, A.; Sajed, T.; Guo, A.C.; Djoumbou, Y.; Knox, C.; Wilson, M.; Liang, Y.;
Grant, J.; et al. T3DB: The toxic exposome database. Nucleic Acids Res. 2015, 43, D928–D934. [CrossRef]
59. Warth, B.; Spangler, S.; Fang, M.; Johnson, C.H.; Forsberg, E.M.; Granados, A.; Martin, R.L.;
Domingo-Almenara, X.; Huan, T.; Rinehart, D.; et al. Exposome-Scale Investigations Guided by Global
Metabolomics, Pathway Analysis, and Cognitive Computing. Anal. Chem. 2017, 89, 11505–11513. [CrossRef]
60. Walker, D.I.; Uppal, K.; Zhang, L.; Vermeulen, R.; Smith, M.; Hu, W.; Purdue, M.P.; Tang, X.; Reiss, B.;
Kim, S.; et al. High-resolution metabolomics of occupational exposure to trichloroethylene. Int. J. Epidemiol.
2016, 45, 1517–1527. [CrossRef]
61. Carlsten, C.; Blomberg, A.; Pui, M.; Sandstrom, T.; Wong, S.W.; Alexis, N.; Hirota, J. Diesel exhaust augments
allergen-induced lower airway inflammation in allergic individuals: A controlled human exposure study.
Thorax 2016, 71, 35–44. [CrossRef] [PubMed]
62. Mookherjee, N.; Piyadasa, H.; Ryu, M.H.; Rider, C.F.; Ezzati, P.; Spicer, V.; Carlsten, C. Inhaled diesel exhaust
alters the allergen-induced bronchial secretome in humans. Eur. Respir. J. 2018, 51. [CrossRef] [PubMed]
63. Brook, J.R.; Setton, E.M.; Seed, E.; Shooshtari, M.; Doiron, D.; CANUE—The Canadian Urban Environmental
Health Research Consortium. The Canadian Urban Environmental Health Research Consortium—A protocol
for building a national environmental exposure data platform for integrated analyses of urban form and
health. BMC Public Health 2018, 18, 114. [CrossRef] [PubMed]
64. David, A.; Lange, A.; Abdul-Sada, A.; Tyler, C.R.; Hill, E.M. Disruption of the Prostaglandin Metabolome and
Characterization of the Pharmaceutical Exposome in Fish Exposed to Wastewater Treatment Works Effluent
As Revealed by Nanoflow-Nanospray Mass Spectrometry-Based Metabolomics. Environ. Sci. Technol. 2017,
51, 616–624. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
